Skip to main content

Smarter Patent Strategy in the Age of AI

In this Medical Product Outsourcing article, Greenberg Traurig Shareholder David J. Dykeman examines how the USPTO’s integration of AI into patent examination is reshaping patent strategy for medtech companies. Dykeman discusses the importance of stronger initial patent applications, strategic continuation planning, and proactive IP protection to help innovators navigate AI-assisted examination and secure commercially meaningful patent rights.

LINKS

Read “Smarter Patent Strategy in the Age of AI” on the Medical Product Outsourcing website.

Click the media link below to download the PDF.